| Current Price | $40.81 | Mkt Cap | $1.9B |
|---|---|---|---|
| Open | $40.61 | P/E Ratio | 47.27 |
| Prev. Close | $40.81 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $40.36 - $40.92 | Volume | 306,182 |
| 52-Wk Range | $35.35 - $82.16 | Avg. Daily Vol. | 547,576 |
| Current Price | $40.81 | Mkt Cap | $1.9B |
|---|---|---|---|
| Open | $40.61 | P/E Ratio | 47.27 |
| Prev. Close | $40.81 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $40.36 - $40.92 | Volume | 306,182 |
| 52-Wk Range | $35.35 - $82.16 | Avg. Daily Vol. | 547,576 |
The best Bull and Bear pitches based on recency and number of recommendations.
The company will benefit from the expanded label of its lead drug, Exparel, In addition, many elective surgeries that were put off during the pandemic will likely happen once it ebbs later this year, increasing business for Pacira.
The commercial success of Exparel is a tough call to make. Intuitively, the drug seems to be filling an important niche in post-operative pain management. But empirical evidence tells us that launches of new drugs are usually slow, and expecially in… More
Read the most recent pitches from players about PCRX.
Recs
TMFjimhalley
(< 20)
Submitted: 3/24/2021 9:52:51 AM :
Start Price:
$70.14
NASDAQ:PCRX Score:
-46.33
The company will benefit from the expanded label of its lead drug, Exparel, In addition, many elective surgeries that were put off during the pandemic will likely happen once it ebbs later this year, increasing business for Pacira.
Recs
jonnycd
(< 20)
Submitted: 2/24/2021 10:57:39 AM :
Start Price:
$77.62
NASDAQ:PCRX Score:
-52.58
Great product that not being fully utilized yet
Recs
TMFSarahGen
(95.00)
Submitted: 8/4/2016 2:50:53 PM :
Start Price:
$44.87
NASDAQ:PCRX Score:
-97.88
non opioid pain meds
Find the members with the highest scoring picks in PCRX.
TrackBreanMurray (< 20) Score: +409.62
The Score Leader is the player with the highest score across all their picks in PCRX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| IPOMizzouFanVan | 61.70 | 2/7/2011 |
|
3Y | $7.01 | +482.30% | +208.94% | +273.36 | 0 Comment | |
| ChristopherHamel | 80.55 | 11/28/2011 |
|
5Y | $7.25 | +462.62% | +241.61% | +221.01 | 0 Comment | |
| locochango | 83.66 | 11/7/2011 |
|
5Y | $7.66 | +432.51% | +225.67% | +206.83 | 0 Comment | |
| wahodges | 88.17 | 5/19/2014 |
|
5Y | $75.09 | -45.68% | +117.57% | +163.25 | 0 Comment | |
| CocaineOrStock | 93.90 | 7/15/2014 |
|
5Y | $86.81 | -53.01% | +106.94% | +159.96 | 0 Comment | |
| PatientTrader | < 20 | 11/2/2011 |
|
5Y | $8.89 | +358.83% | +229.22% | +129.61 | 0 Comment | |
| MightySaint | 28.42 | 4/16/2013 |
|
5Y | $29.04 | +40.45% | +161.55% | +121.10 | 0 Comment | |
| SaiyanBroker | 88.38 | 3/18/2013 |
|
NS | $28.00 | +45.68% | +162.40% | +116.73 | 0 Comment | |
| OriginalBarnacle | 66.71 |
|
|
1Y | $27.72 | +47.15% | +162.71% | +115.56 | 0 Comment | |
| FUZZYMINKINS | < 20 | 8/1/2011 |
|
5Y | $10.06 | +305.47% | +212.11% | +93.36 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
